Vastarel OD

Vastarel OD

trimetazidine

Manufacturer:

Servier

Distributor:

DKSH
Concise Prescribing Info
Contents
Trimetazidine diHCl
Indications/Uses
Add-on therapy for symptomatic treatment of adult patients w/ stable angina pectoris who are inadequately controlled by or intolerant to 1st-line anti-anginal therapies.
Dosage/Direction for Use
80 mg once daily. Moderate renal impairment (CrCl 30-60 mL/min) Recommended dose: 35 mg in the morning.
Contraindications
Hypersensitivity. Parkinson disease, parkinsonian symptoms, tremors, restless leg syndrome, & other related movement disorders. Severe renal impairment (CrCl <30 mL/min).
Special Precautions
Not a curative treatment for angina attacks, nor as initial treatment for unstable angina or MI, nor in pre-hospital phase or during 1st days of hospitalisation. Worsen parkinsonian symptoms (tremor, akinesia, hypertonia). Falls related to gait instability or hypotension. Fructose intolerance, glucose-galactose malabsorption or sucrose-isomaltase insufficiency. May affect ability to drive & use machines. Moderate renal impairment. Avoid use during pregnancy. Not to be used during lactation. Childn <18 yr. Elderly >75 yr.
Adverse Reactions
Dizziness, headache; abdominal pain, diarrhoea, dyspepsia, nausea & vomiting; rash, pruritus, urticaria; asthenia.
MIMS Class
Anti-Anginal Drugs
ATC Classification
C01EB15 - trimetazidine ; Belongs to the class of other cardiac preparations.
Presentation/Packing
Form
Vastarel OD PR cap 80 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in